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Letter to the Editor JCDR
Potential of probiotics in 
controlling cardiovascular 
diseases
Sir,
The World Health Organization and the Food and 
Agriculture Organization of the United Nations have 
deﬁ  ned probiotics as “live microorganisms, which, when 
administered in adequate amounts, confer a health beneﬁ  t 
on the host.” They are also called “friendly bacteria” 
or “good bacteria.” The concept of probiotics arose 
at the turn of the 20th century from a hypothesis ﬁ  rst 
proposed by the Noble Prize-winning Russian scientist, 
Elie Metchnikoff. Most probiotics fall into the group of 
organisms known as lactic acid-producing bacteria, and are 
normally consumed in the form of yogurt, fermented milks 
or other fermented foods.[1,2] The valuable effects of food 
with added live microbes (probiotics) on human health 
and, in particular, of milk products, are being increasingly 
promoted by health professionals, and these probiotics can 
play an important role in systemic health of the person.
Coronary heart disease (CHD) is caused by a narrowing 
of the coronary arteries that feed the heart. It is the 
most common form of heart disease, affecting some 7 
million Americans, and it is also the number-one killer 
of both men and women. Each year, more than 500,000 
Americans die of heart attacks caused by CHD. Many of 
these deaths could be prevented because CHD is related 
to certain aspects of lifestyle. Some of the risk factors for 
CHD, or things that increase your risk of developing the 
disease, are high blood pressure, high blood cholesterol, 
smoking, obesity, physical inactivity, diabetes and stress. 
Experimental data are convincing in support of the 
hypothesis that prebiotics inhibit hepatic lipogenesis in rats 
and, consequently, induce a signiﬁ  cant hypotriglyceridemic 
effect. Hypothesized mechanisms of this effect include the 
metabolic effects of short-chain carboxylic acids and the 
lowering of glycemia or insulinemia,[3] because a metabolic 
link was recently shown between insulin resistance and the 
associated risk factors for atherosclerotic cardiovascular 
disease, especially hypertriglyceridemia, and because of 
the growing awareness that hypertriglyceridemia itself may 
be a risk factor in atherogenesis. The potential functional 
effects described, primarily of prebiotics, need to be studied 
carefully in humans, especially in conditions known to be 
associated with hyperinsulinemia and hypertriglyceridemia.[3]
Probiotics support the development of regulatory T cells 
in the immune system. Dendritic cells (DC) are antigen-
presenting cells found throughout the gut that continually 
sample enteric antigens and present them to naive T cells, 
resulting in T-cell activation and differentiation. DC is able 
to discriminate between different microbial strains through 
the expression of pattern-recognition receptors that 
recognize speciﬁ  c pathogen-associated molecular patterns. 
Microbes will stimulate DC to acquire signals to drive the 
development of either TH1, TH2 or Treg cell responses. 
Probiotic bacteria induce a pattern of maturation of DC 
characterized by the release of small amounts of tumor 
necrotic factor-α and IL-12, with increased levels of IL-
10, and inhibit the generation of proinﬂ  ammatory TH1 
cells. Biﬁ  dobacteria in particular induce an upregulation 
of IL-10 production by DC and decrease the expression 
of the costimulatory molecules, CD80 and CD40. This 
increase in IL-10 production may act both by having direct 
antiinﬂ  ammatory effects and by enhancing the generation 
of Treg cells. In contrast to the effects of Biﬁ  dobacteria, 
some Lactobacilli strains tend to generate a phenotype 
of DC characterized by increased costimulatory marker 
expression but low production of proinflammatory 
cytokines.[4] These T cells help reduce overzealous immune 
responses throughout the body. What that can mean are 
fewer number of white blood cells being sent to a damaged 
artery and, therefore, less inﬂ  ammation and less chance of 
accumulation of cholesterol in the area. Probiotics help 
reduce blood cholesterol in three different ways:
Probiotics create acids that counter cholesterol production: 
As probiotic bacteria absorb ﬁ  ber from the intestines, they 
generate acids. One of the speciﬁ  c acids, i.e. proprionic 
acid, reduces production of cholesterol by the liver.
Probiotics break down liver bile acids: Bile acids assist body 
in digesting fats, and the liver produces these bile acids 
from cholesterol. The liver recycles bile acids and utilizes 
them over and over. Probiotics break down bile acids and, 
therefore, the liver has to make additional bile acids, using 
up more cholesterol in the progression.
Probiotics actually eat cholesterol: Probiotic bacteria have 
been shown to break down cholesterol and use it for 
nourishment.
Thus, it can be concluded that probiotics can be 
included in foodstuffs through new technologies like 
microencapsulation and immobilized cell technologies. Letter to the Editor
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Further research in this area may offer exciting avenues in 
health care strategies.[2] Scientiﬁ  c evidence exists to indicate 
that there is potential for the derivation of health beneﬁ  ts 
from consuming food containing probiotics. However, it 
was felt that additional research data are needed to conﬁ  rm 
a number of these health beneﬁ  ts in humans.this bacterium 
in the mouth and other parts of the human body? Indian 
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